News | June 21, 2026
LabGenius and LG Chem strike AI-powered deal to develop next-gen tumour-targeting antibody therapy
The collaboration is focused on overcoming a major limitation in existing cancer drugs
The collaboration is focused on overcoming a major limitation in existing cancer drugs
Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships
Enhanced CMC infrastructure at Cranbury site aims to improve bioavailability, streamline formulation development and support faster progression of challenging drug candidates into clinical trials
The company will present 21 oral and poster presentations spanning investigational and approved therapies
Veteran healthcare leader to oversee operations across Tamil Nadu and Kerala, driving growth and operational excellence
The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials
The safety profile was described as manageable, though not without notable toxicities
Derived from rice bran wax, Licocare RBW products offer a renewable solution with a substantially lower carbon footprint than conventional montan waxes
Selected ventures to receive grants and structured intellectual property support to strengthen protection and management of healthcare innovations
Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
